Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05729477 · ClinicalTrials.gov registry record · NA
A Prospective Multicenter Study To Assess The Clinical Outcomes Of Current Phacoemulsification Approach To Cataract Extraction Versus The Micor System Device
A NA study, sponsored by Carl Zeiss Meditec.
- Terminated
- Registry status
- NA
- Development phase
- 402
- Enrollment target
NCT05729477 is a NA study that was terminated before completion, run by Carl Zeiss Meditec. The registered enrollment target is 402 participants.
The verdict
NCT05729477, a NA study, was terminated before completion, sponsored by Carl Zeiss Meditec.
- TERMINATED
- Registry status
- NA
- Development phase
- 402 participants
- Enrollment target
Study Summary
The purpose of this research study is to evaluate the clinical outcomes of current phacoemulsification approaches to cataract extraction involving high-frequency thermogenic energy versus the use of the MICOR System device using low-energy segment removal with a micro-interventional irrigation/aspiration port to evacuate the lens in subjects undergoing routine cataract surgery.
Interventions
- DEVICE miCOR System
- DEVICE Phaco Subject Cohort
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 402 participants |
| Start Date | 2022-12-06 |
| Est. Completion | 2025-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05729477
The ClinicalTrials.gov registry entry for NCT05729477 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 402 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Carl Zeiss Meditec, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which miCOR System is the first listed.
NCT05729477 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05729477 about?
NCT05729477 is a clinical study titled "A Prospective Multicenter Study To Assess The Clinical Outcomes Of Current Phacoemulsification Approach To Cataract Extraction Versus The Micor System Device". The purpose of this research study is to evaluate the clinical outcomes of current phacoemulsification approaches to cataract extraction involving high-frequency thermogenic energy versus the use of the MICOR System device using low-energy segment removal with a micro-interventional irrigation/aspir...
What is the current status of trial NCT05729477?
This trial is currently terminated. It is a NA study. The enrollment target is 402 participants. The study started on 2022-12-06. Estimated completion is 2025-12-30.
What interventions are being tested in trial NCT05729477?
The interventions under investigation include: miCOR System (DEVICE), Phaco Subject Cohort (DEVICE).
Who is sponsoring clinical trial NCT05729477?
This trial is sponsored by Carl Zeiss Meditec, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.